EUVIMEDΑνακαλύψτε το EUVIMED
Crossref

First Cases of Allergic Contact Dermatitis From the New FreeStyle Libre 3 Sensor: Small Device, Multiple Allergens

Silada Kanokrungsee iD, Ella Dendooven iD, Kenn Foubert iD, Tania Naessens iD, Emmy Tuenter iD, Nina Hermans iD, Olivier Aerts

Contact Dermatitis · 2026-11-18

DOI: 10.1111/cod.70287 ↗

At a glance

Journal article in Contact Dermatitis, published online on 2026-11-18. Written by Silada Kanokrungsee and 6 co-authors. Institution: Department of Dermatology, University Hospital Antwerp (UZA) and Research Group Immunology, INFLA-MED Centre of Excellence, University of Antwerp, An…. 45 references.

ΠερίληψηΒιβλιογραφικά στοιχείαCiteRelated studies

Abstract (original language)

Background

Allergic contact dermatitis (ACD) from glucose sensors has become increasingly common. Newer devices, such as FreeStyle Libre 3 (Abbott Diabetes Care, UK), have been developed to enhance performance and reduce skin reactions. No ACD cases linked to this particular device have been reported to date.

Objective

To document the first cases of ACD linked to the FreeStyle Libre 3 sensor and to identify potential culprit allergenic components through patch testing and chemical analyses.

Methods

A retrospective chart review was conducted on 15 patients with suspected ACD related to the FreeStyle Libre 3 device who underwent patch testing at Antwerp University Hospital between November 2023 and November 2025. Chemical analyses of the device and associated adhesive components were performed using gas chromatography–mass spectrometry (GC–MS).

Results

Ten patients (67%) were diagnosed with ACD and most had prior exposure to other glucose sensors. The most frequent allergens were colophonium and related compounds, followed by (meth)acrylates, isocyanates and tert‐butylphenol (TBP) derivatives. GC–MS analyses revealed the presence of most of these chemicals.

Conclusions

Multiple newly identified as well as (modified) classic sensitizers contribute to ACD from the FreeStyle Libre 3 glucose sensor. Comprehensive ingredient disclosure and extended patch testing are essential for accurate diagnosis and prevention.

Authors and institutions

  • Department of Dermatology, University Hospital Antwerp (UZA) and Research Group Immunology, INFLA-MED Centre of Excellence, University of Antwerp, Antwerp, Belgium.
  • Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Natural Products and Food Research and Analysis - Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium.

ORCID profiles: Silada Kanokrungsee, Ella Dendooven, Kenn Foubert, Tania Naessens, Emmy Tuenter, Nina Hermans

Cite

APA

Kanokrungsee, S., Dendooven, E., Foubert, K., Naessens, T., Tuenter, E., Hermans, N., & Aerts, O. (2026). First Cases of Allergic Contact Dermatitis From the New FreeStyle Libre 3 Sensor: Small Device, Multiple Allergens. Contact Dermatitis. https://doi.org/10.1111/cod.70287

Vancouver

Kanokrungsee S, Dendooven E, Foubert K, Naessens T, Tuenter E, Hermans N, et al. First Cases of Allergic Contact Dermatitis From the New FreeStyle Libre 3 Sensor: Small Device, Multiple Allergens. Contact Dermatitis. 2026. doi:10.1111/cod.70287

BibTeX
@article{Kanokrungsee2026,
  author = {Kanokrungsee, Silada and Dendooven, Ella and Foubert, Kenn and Naessens, Tania and Tuenter, Emmy and Hermans, Nina and Aerts, Olivier},
  title = {First Cases of Allergic Contact Dermatitis From the New FreeStyle Libre 3 Sensor: Small Device, Multiple Allergens},
  journal = {Contact Dermatitis},
  year = {2026},
  doi = {10.1111/cod.70287}
}
Start for free →